Allergic Rhinitis Due to Grass Pollen Clinical Trial
Official title:
Efficacy of Puressentiel Protective Nasal Spray on Symptoms and Inflammation in Patients With in Allergic Rhinitis
This study is a proof o concept aiming to determine the efficacy of Puressentiel nasal protective spray (PNPS) in patients with allergic rhinitis. Cross over study, with a nasal provocative test (NPT) in patients with allergic rhinitis sensitized to grass pollen. A day 0 (first NPT) the following outcomes are recorded: allergic Rhinitis control test (ARCT) and Inspiratory nasal peak flow (INPF) before and 30 min after the NPT. Nasal lavage is performed 30 min after the NPT and 3 cytokines (IL4, IL5 and IL13 are measured by ELISA. An other NPT is performed at day 30 and the same outcomes measured. 30 min before NPT 2 nasal sprays of PNPS are administered in each nostril in a randomized manner and cross over, the patient being is own control. The primary outcomes ins the IL4, IL5 and IL13 concentrations in the nasal lavage. ARCT and INPF are the secondary outcomes.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03290248 -
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
|
Phase 1/Phase 2 | |
| Completed |
NCT06104293 -
Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber
|
N/A | |
| Completed |
NCT04878237 -
Kinetics of Nasal Cytokine Responses to Mechanical Stimulation
|
N/A | |
| Completed |
NCT04802616 -
The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells
|
Phase 3 | |
| Active, not recruiting |
NCT05297760 -
Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06061848 -
Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT
|
Phase 2/Phase 3 | |
| Completed |
NCT05037955 -
ILIT: Follow-up of Rhinitis Quality of Life
|
||
| Active, not recruiting |
NCT05191186 -
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
|
Phase 3 | |
| Completed |
NCT04210193 -
Is Intralymphatic Allergen Immunotherapy Effective and Safe?
|
Phase 2/Phase 3 | |
| Completed |
NCT01953471 -
Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)
|
N/A |